Skip to content

Pilot Study of SuperSeton Placement in Patients with Perianal Fistulas

Pilot Study of SuperSeton Placement in Patients with Perianal Fistulas - SuperSeton Pilot Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON45970
Enrollment
60
Registered
2016-07-27
Start date
2016-08-10
Completion date
Unknown
Last updated
2024-04-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

perianal fistula

Interventions

The SuperSeton will be placed at the outpatient clinic in patients that already have a seton in situ. This seton will then be exchanged by the SuperSeton. In case patient do not have a seton in situ

Sponsors

Academisch Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Patients of 18 years or older - Written informed consent - Perianal fistulas for which a seton was placed that is still in situ or recurrent perianal fistulas (ever treated with a knotted seton) for which a new seton will be placed

Exclusion criteria

Exclusion criteria: - Patients with a pacemaker or an ICD in situ - Rectovaginal fistula - Patients with a stoma - Life expectancy

Design outcomes

Primary

MeasureTime frame
Main study parameters/endpoints: The primary outcome is seton failure (loosening of the seton).

Secondary

MeasureTime frame
Secondary outcomes are time of procedure, complications and quality of life measured by the PDAI (*Perianal Disease Activity Index*).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)